Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials. (Record no. 25006004)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01397 a2200373 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517040111.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201703s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1973-9478 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1179/1973947815Y.0000000053 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Wang, Zexing |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20170315 |
| 245 00 - TITLE STATEMENT | |
| Title | Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Journal of chemotherapy (Florence, Italy) |
| Date of publication, distribution, etc. | Aug 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 328-34 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Meta-Analysis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gastrointestinal Diseases |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Incidence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Intestinal Perforation |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Risk |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ramucirumab |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhang, Jun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhang, Liang |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Pengying |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Xie, Yamin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhou, Qin |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal of chemotherapy (Florence, Italy) |
| Related parts | vol. 28 |
| -- | no. 4 |
| -- | p. 328-34 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1179/1973947815Y.0000000053">https://doi.org/10.1179/1973947815Y.0000000053</a> |
| Public note | Available from publisher's website |
No items available.